Constellation: MorphoSys : Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals (Form 6-K)

(marketscreener.com) developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc., for the treatment of plaque psoriasis - became the first drug based on MorphoSys' antibody technology to receive regulatory approval. In July 2020, the U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product...https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/MorphoSys-nbsp-Commences-Cash-Tender-Offer-for-All-Outstanding-Shares-of-Constellation-Pharmaceuti-35631233/?utm_medium=RSS&utm_content=20210617